Dacotin RTU 100mg Injection

Dacotin RTU 100mg Injection is classified as a platinum-based antineoplastic agent. Its active component is Oxaliplatin. This medication is indicated for the treatment of stage 3 colon cancer following the surgical removal of the primary tumor, as well as for metastatic cancer of the colon and rectum. It is typically administered alongside other anti-cancer therapies. Colorectal cancer primarily arises in the rectum and large intestine and is the result of various genetic mutations accumulating over time. Both genetic and environmental factors significantly contribute to the development of colorectal cancer. This drug is effective against tumors that have shown resistance to cisplatin treatment.

Common side effects associated with Dacotin RTU 100mg Injection may include a decrease in blood cell count, a sensation of discomfort in the throat, diarrhea, nausea, vomiting, indigestion, heartburn, blood clots, hematuria, hypertension, depression, insomnia, and low calcium levels. It is important to notify your doctor if any of these side effects become bothersome or persist.

If you have a known allergy to Dacotin RTU 100mg Injection or any of its components, inform your doctor. Prior to commencing treatment with this medication, it is essential to inform your physician if you have moderate to mild kidney issues, liver conditions, or heart problems. Additionally, disclose all medications you are currently taking, including any vaccinations. This medication is not advised for use in pregnant or breastfeeding women.